Device Trials Require Unique Financial Conflict Of Interest Solution
This article was originally published in The Gray Sheet
Executive Summary
HHS should tailor its approach to disclosure of financial conflict of interest in device clinical trials vis avis pharmaceutical studies, AdvaMed (formally HIMA) Executive VP-Technology and Regulatory Affairs Jim Benson maintained.
You may also be interested in...
FDA Civil Monetary Penalties For Human Subject Protection Sought By HHS
HHS plans to submit a legislative proposal to Congress by year-end that would authorize FDA to levy civil monetary penalties for infractions of human research subject protections rules, the Clinton administration announced May 23.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.